News

Laramide's 2024 Drill Campaign Opens New Uranium Prospects

Laramide's 2024 Drill Campaign Opens New Uranium Prospects

Exciting Drilling Results from Laramide Resources

Highlights:

  • Laramide achieved its largest drilling campaign ever, completing 106 holes.
  • Multiple exploration targets were successfully tested, demonstrating extensive mineralization potential in various styles.
  • Key findings reinforce Westmoreland as a future vital source for global uranium supply.
  • Numerous follow-up exploration targets remain available for future campaigns.

Laramide Resources Ltd. (TSX: LAM, OTCQX: LMRXF) is proud to announce the completion of its most extensive drill program at the Westmoreland Uranium Project. The campaign delivered successful results that promise to enhance the understanding of the deposit’s quality and size.

The main aim of the 2024 drill program was to enrich the mineral resource at Westmoreland through strategic infill and extensional drilling of uranium mineralization. Additionally, the campaign focused on identifying the potential for gold mineralization while also advancing logistical and targeting assessments at related satellite deposits.

Results from the drilling program showcased broad and significant mineralization across various areas. Certain intercepts encapsulated narrower yet high-grade mineralized zones, suggesting a complex yet inviting geological structure within Westmoreland.

The drilling efforts at Junnagunna yielded impressive outcomes, including broad intercepts. Recent reports highlighted results from eleven infill holes at Junnagunna, three holes at Amphitheatre, and two exploratory holes from the Southern Comfort-Mageera Trend. Notably, the entire campaign encompassed 106 holes, which included 60 Reverse Circulation (RC) and 46 Diamond Drilling (DD) holes across a total of approximately 11,263 meters.

Rhys Davies, Laramide’s Vice-President of Exploration, mentioned, "The 2024 drill campaign signifies our most thorough endeavor to date, demonstrating not only the quality but also the scalability of the Westmoreland asset. We remain dedicated to maximizing this project's potential and its contributions to the uranium supply chain."

Detailed Project Insights

Infill Drilling at Junnagunna

The results from the Junnagunna deposit continue to support existing geological models, confirming both lateral and vertical mineralization continuity. Data suggests that high-grade intercepts exist within broader mineralized zones, supporting further exploration efforts.

  • Significant results included JG24DD004: 8.00m @ 325.61 ppm U3O8, with notable intersections of high-grade uranium.
  • JG24DD010: 10.00m @ 693.90 ppm U3O8 enhanced confidence in locating additional uranium deposits.

Future exploration at Junnagunna is aimed at delineating the extents of mineralization, particularly the extensions to the northeast, where opportunities for new discoveries remain open.

Progress at Amphitheatre

The Amphitheatre site saw the deployment of eight diamond holes totaling 1,334.55 meters. The initial results underscored the potential for both surface and deep mineralization targets, hinting at substantial resources awaiting further evaluation.

Exploration at Southern Comfort/Mageera

The recent drilling at the Southern Comfort prospect assessed the northeastern fault's potential while also considering uranium, vanadium, and rare earth elements near the geological structures comparable to Westmoreland’s setting. The findings from this drilling led to promising advancements in identifying economic minerals.

Looking Ahead

Laramide continues to focus on high-quality uranium assets in Tier-1 jurisdictions. The company has strategically chosen its assets for both size and production potential. Furthermore, the exploration in Kazakhstan seeks to uncover world-class roll-front deposits, enhancing its resource portfolio significantly.

As the company moves forward, the commitment to expanding underexplored avenues remains steadfast, solidifying its position as a key player in the uranium market.

Frequently Asked Questions

What were the highlights of Laramide's 2024 drill campaign?

Laramide completed its largest drill program with 106 holes and confirmed significant potential for uranium and gold mineralization.

Which areas were focused on during the drilling?

The main targets included the Junnagunna deposit, the Amphitheatre site, and the Southern Comfort/Mageera region.

What were the notable results from the drill program?

Broad intercepts of mineralization were observed, including significant grades of uranium at the Junnagunna location.

What are the future plans for Laramide's projects?

Laramide aims to enhance the exploration efforts at Westmoreland while maintaining a focus on high-potential sites in both existing and new projects.

How does Laramide position itself in the uranium market?

Laramide is strategically developing high-quality uranium assets in favorable jurisdictions, looking to play a key role in meeting worldwide uranium demand.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ridero Innovates with $2.7M to Tackle Auto Finance Woes

Updated Category News Views 93

Ridero Gets Serious About Fixing Auto Financing When you've got startups like Ridero stepping up with a $2.7 million cash infusion, you can't help but sit up and listen. These folks are charging head-on into the automotive financing jumble, and they're bringing some high-tech toys to the party. With RiverPark Ventures and a slew of other big-name backers, Ridero's dialing...

Continue Reading
Gildan Faces Class Action Over Alleged Market Missteps

Updated Category News Views 64

Legal Storm Brews Over Gildan's Securities Conduct Listen, investors are no strangers to turbulence. But when a company's integrity takes a nosedive, that's when things get precarious fast. Gildan Activewear Inc. (NYSE: GIL) finds itself neck-deep in legal trouble, thanks to alleged securities law violations. On November 9, 2026, DJS Law Group got the ball rolling on a...

Continue Reading
Western Digital Faces Investigation Over Fiduciary Breaches

Updated Category News Views 42

Ringside Seat to Western Digital's Legal Turbulence If there's one thing that'll make an investor's hair stand on end, it's the whisper of fiduciary breaches. Western Digital Corporation (NASDAQ:WDC) just took a hit from Levi & Korsinsky, LLP, who've launched a full-scale investigation into potential breaches of fiduciary duties by select officers and directors. When a...

Continue Reading
Ericsson Buybacks: Strategic Moves or Market Maneuver?

Updated Category News Views 106

Breaking Down Ericsson's Strategic Share Buybacks When a company like Ericsson starts pulling stocks off the shelves like they're on sale, it's time to take notice. Between November 2nd and 6th, Ericsson, that telecom giant we all know, went on a little shopping spree, snapping up 500,000 of its own Class B shares. Why should we care? Well, it's a part of their hefty SEK...

Continue Reading
Energenesis Tackles Space Anemia with ATP Boost

Updated Category News Views 59

Gearing Up for Space Medicine: Enter Energenesis With the cosmic frontier drawing investor eyes and day-to-day operations inching skyward, here comes Energenesis Biomedical (TWSE: 6657), poking its head into space medicine. This isn’t just another biotech firm looking to throw drugs at terrestrial problems. No, Energenesis shot its shot at TASTI 2026 with its...

Continue Reading
CD Rates on the Rise: What Savers Need to Know

Updated Category News Views 23

CD Rates: A Change in the Winds If you think of certificates of deposit (CDs) like a quiet corner booth at your local bar, you might be in for a surprise. Right now, it feels like the DJ just turned up the volume. We've seen a noteworthy 88% of rate changes heading upward lately, according to CD Valet's latest data. In numbers that speak loud and clear, the median CD rate...

Continue Reading
NSAP's First Board Aims to Revolutionize Autism Care

Updated Category News Views 11

Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...

Continue Reading
Paul Taubman Takes Helm at Cold Spring Harbor Lab

Updated Category News Views 217

Paul Taubman Steers the Ship at CSHL Here's the buzz coming out of Cold Spring Harbor Lab: they're handing the reins over to Paul Taubman. It's like swapping captains in the middle of the ocean—big shoes need to stay afloat. This place isn't just the playground for science nerds; it's a powerhouse in biomedical research. Now, we've got Taubman, a fella who's been...

Continue Reading
Quest Diagnostics at Jefferies Conference: What’s Next?

Updated Category News Views 54

Quest Diagnostics Set for the Spotlight in London You're sipping your morning coffee when you hear that Quest Diagnostics (NYSE: DGX) is gearing up for a fireside chat in the UK's capital. Now, this isn't a random chit-chat we're talking about. Sam Samad, the man handling the books as their CFO, will be chatting it up at the Jefferies Global Healthcare Conference on...

Continue Reading
Creality's Kid-Friendly AI 3D Printer Debuts at $329

Updated Category News Views 7

Creality Unpacks mBox for Young Innovators You squint at the market to find the next big thing, and here comes Creality tossing a fancy innovation into the ring. Meet the mBox—a kid-operated, AI-driven 3D printer. This little contraption is set to spark youthful imagination, not just buzz amongst hobbyist circles. They're rolling this out on TikTok Shop from November 9...

Continue Reading

Top 5 Most Recently Viewed Articles

Potential Legal Scrutiny for aTyr Pharma: Seeking Justice for Investors

Updated Category News Views 298

Overview of aTyr Pharma, Inc. aTyr Pharma, Inc. is a biotechnology firm devoted to advancing innovative therapies for patients with rare diseases. The company focuses on immunological and neurological disorders, working diligently to bring solutions to underserved markets. As the company navigates through the complexities of drug development, it also faces scrutiny...

Continue Reading
Signs of Needing Home Care: Key Insights from Experts

Updated Category News Views 42

Spotting the Subtle Shifts Navigating the path of aging isn't exactly a walk in the park, and families often find themselves squinting to see the subtle signs that an aging parent might need a little more than just occasional check-ins. We’re not talking dramatic meltdowns here—no, it’s about those creeping changes that sneak in like an old song you haven’t heard...

Continue Reading
UPLIZNA® Receives FDA Approval for Generalized Myasthenia Gravis

Updated Category News Views 164

UPLIZNA® Gains FDA Approval for gMG in Adults UPLIZNA is an innovative new treatment for adults battling generalized myasthenia gravis (gMG), a debilitating autoimmune disorder. This approval, granted by the U.S. Food and Drug Administration (FDA), heralds a new era for gMG patients, providing them with deep and durable control over their symptoms. The most appealing...

Continue Reading
Monster Energy Launches Refreshing Strawberry Shot Variant

Updated Category News Views 254

Monster Energy Unveils Strawberry Shot Monster Energy is thrilled to announce the introduction of Monster Energy Strawberry Shot, set to captivate fans with its unique twist on the classic OG flavor. This new version infuses the iconic energy blend with an enticing hint of strawberry, promoting an enjoyable and refreshing experience. A Fresh Take on a Classic Favorite...

Continue Reading
Cohen & Steers Quarterly Performance Insights and Future Outlook

Updated Category News Views 163

Cohen & Steers Quarterly Performance Insights Cohen & Steers, Inc. (NYSE: CNS) announced its financial outcomes for the recent quarter ending on June 30. This report sheds light on the firm’s commitment to delivering exceptional results in the investment management sector. Understanding the Second Quarter Financials The recent financial report reflects the company’s...

Continue Reading